Bio-Techne Corporation

(NASDAQ:TECH)

Latest On Bio-Techne Corporation (TECH):

Date/Time Type Description Signal Details
2019-12-06 17:19 ESTInsider TradeHAROLD J WIENS has directly disposed of 80 shares and currently holds 5,221 shares.Sell
2019-12-06 17:19 ESTInsider TradeHAROLD J WIENS has directly disposed of 921 shares and currently holds 5,301 shares.Sell
2019-12-06 17:19 ESTInsider TradeHAROLD J WIENS has directly disposed of 514 shares and currently holds 6,222 shares.Sell
2019-12-06 17:19 ESTInsider TradeHAROLD J WIENS has directly acquired 2,000 shares and currently holds 7,221 shares.Buy
2019-12-06 17:19 ESTInsider TradeHAROLD J WIENS has directly disposed of 485 shares and currently holds 6,736 shares.Sell
2019-12-02 17:07 ESTInsider TradeCharles R. Kummeth has directly disposed of 100 shares and currently holds 135,756 shares.Sell
2019-12-02 17:07 ESTInsider TradeCharles R. Kummeth has directly disposed of 11,772 shares and currently holds 135,856 shares.Sell
2019-12-02 17:07 ESTInsider TradeCharles R. Kummeth has directly acquired 11,772 shares and currently holds 147,628 shares.Buy
2019-11-29 12:57 ESTInsider TradeRoeland Nusse has directly disposed of 8,347 shares and currently holds 12,374 shares.Sell
2019-11-29 12:57 ESTInsider TradeRoeland Nusse has directly acquired 5,000 shares and currently holds 20,721 shares.Buy
2019-11-29 12:57 ESTInsider TradeRoeland Nusse has directly acquired 10,000 shares and currently holds 15,721 shares.Buy
2019-11-29 00:28 ESTFinancialsCompany financials have been released.Neutral
2019-11-28 00:39 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 00:39 ESTFinancialsCompany financials have been released.Neutral
2019-11-25 17:12 ESTInsider TradeJames Hippel has directly disposed of 1,600 shares and currently holds 9,307 shares.Sell
2019-11-25 17:12 ESTInsider TradeJames Hippel has directly disposed of 22,051 shares and currently holds 10,907 shares.Sell
2019-11-25 17:12 ESTInsider TradeJames Hippel has directly acquired 23,651 shares and currently holds 32,958 shares.Buy
2019-11-25 17:12 ESTInsider TradeJames Hippel has directly acquired 11,349 shares and currently holds 20,656 shares.Buy
2019-11-25 17:12 ESTInsider TradeJames Hippel has directly disposed of 11,349 shares and currently holds 9,307 shares.Sell
2019-11-25 04:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $240 to $239.Neutral
2019-11-23 00:16 ESTAnalyst RatingThe Analyst Target Price has increased from $239 to $240.Buy
2019-11-19 15:54 ESTNewsBIO-TECHNE (TECH) Presents At Stifel Healthcare Conference - SlideshowN/A
2019-11-18 04:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $240 to $239.Neutral
2019-11-16 07:33 ESTNewsStocks To Watch: Retailers, Dubai Airshow And CybertrucksN/A
2019-11-16 00:39 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 09:15 ESTNewsStifel likes Illumina in premarket analyst actionN/A
2019-11-14 00:18 ESTFinancialsCompany financials have been released.Neutral
2019-11-07 00:34 ESTFinancialsCompany financials have been released.Neutral
2019-10-29 12:17 ESTNewsBio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2020 Results - Earnings Call TranscriptN/A
2019-10-29 06:40 ESTNewsBio-Techne declares $0.32 dividendN/A
2019-10-29 06:34 ESTNewsBio-Techne EPS in-line, beats on revenueN/A
2019-10-29 01:05 ESTEarningsEarnings have been released on October 29, 2019, with $1.06 earnings per share.Buy
2019-10-29 01:05 ESTDividendA dividend of $0.32 has been announced on Oct 29, 2019. It will be paid Nov 22, 2019 with an ex-dividend date of Nov 7, 2019.Neutral
2019-10-28 17:30 ESTNewsBio-Techne Q1 2020 Earnings PreviewN/A
2019-10-24 01:05 ESTInsider TradeAlpna Seth has directly acquired 495 shares and currently holds 1,748 shares.Buy
2019-10-24 01:05 ESTInsider TradeJOSEPH D KEEGAN has directly acquired 495 shares and currently holds 1,748 shares.Buy
2019-10-24 01:05 ESTInsider TradeJOHN L HIGGINS has directly acquired 495 shares and currently holds 4,021 shares.Buy
2019-10-24 01:05 ESTInsider TradeRANDOLPH C STEER has directly acquired 495 shares and currently holds 4,721 shares.Buy
2019-10-24 01:05 ESTInsider TradeHAROLD J WIENS has directly acquired 495 shares and currently holds 5,221 shares.Buy
2019-10-24 01:05 ESTInsider TradeRoeland Nusse has directly acquired 495 shares and currently holds 5,721 shares.Buy
2019-10-24 01:05 ESTInsider TradeRUPERT VESSEY has directly acquired 495 shares and currently holds 642 shares.Buy
2019-10-24 01:05 ESTInsider TradeROBERT V BAUMGARTNER has directly acquired 495 shares and currently holds 9,221 shares.Buy
2019-09-09 01:05 ESTInsider TradeCharles R. Kummeth has acquired 100 shares indirectly via Step-Son.Buy
2019-08-19 01:05 ESTInsider TradeCharles R. Kummeth has directly acquired 24,979 shares and currently holds 135,856 shares.Buy
2019-08-19 01:05 ESTInsider TradeNorman David Eansor has directly acquired 2,287 shares and currently holds 2,287 shares.Buy
2019-08-19 01:05 ESTInsider TradeBrenda S. Furlow has directly acquired 1,759 shares and currently holds 3,948 shares.Buy
2019-08-19 01:05 ESTInsider TradeJames Hippel has directly acquired 4,925 shares and currently holds 9,307 shares.Buy
2019-08-13 01:05 ESTInsider TradeCharles R. Kummeth has directly acquired 7,410 shares and currently holds 110,877 shares.Buy
2019-08-07 01:05 ESTInsider TradeCharles R. Kummeth has directly acquired 11,291 shares and currently holds 103,467 shares.Buy
2019-08-07 01:05 ESTInsider TradeROBERT V BAUMGARTNER has directly acquired 500 shares and currently holds 8,726 shares.Buy

About Bio-Techne Corporation (TECH):

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments and services for the research and clinical diagnostic markets worldwide The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers reagent solutions, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera reagents, and cell selection technologies. This segment also provides analytical solutions, including manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. In addition, it offers various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, such as cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. It has strategic partnership with NanoString Technologies. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

General

  • Name Bio-Techne Corporation
  • Symbol TECH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • Sector Healthcare
  • Industry Biotechnology
  • Full Time Employees 2200
  • Last Split Factor1/2
  • Last Split Date2000-12-04
View More

Valuation

  • Trailing PE 91.84
  • Forward PE 38.41
  • Price/Book (Most Recent Quarter) 7.11
  • Enterprise Value Revenue 11.88
  • Enterprise Value EBITDA 42.6
View More

Financials

  • Current Year EPS Estimate $4.59
  • Next Year EPS Estimate $4.93
  • Next Quarter EPS Estimate $1.30
  • Most Recent Quarter 2019-09-30
  • Profit Margin 0.13
  • Operating Margin 0.22
  • Return on Assets 0.05
  • Return on Equity 0.08
  • Revenue 734.28 million
View More

Highlights

  • Market Capitalization 8.36 billion
  • EBITDA 204.85 million
  • PE Ratio 91.84
  • PEG Ratio 2.99
  • Analyst Target Price $239
  • Book Value $30.83 / share
  • Dividend Per Share $1.28
  • Dividend Yield 0.59%
  • Earnings Per Share $2.39
View More

Share Statistics

  • Shares Outstanding 38.11 million
  • Shares Float 37.9 million
  • % Held by Institutions 95%
  • Shares Short 799771
  • Shares Short Ratio 4.18
  • Short % of Float 0.01%
  • Short % of Shares Outstanding 0.01%
View More

Technicals

  • Beta 1.22
  • 52 Week High $222.87
  • 52 Week Low $132.75
  • 50 Day Moving Average 210.14
  • 200 Day Moving Average 203.62
View More

Dividends

  • Forward Annual Dividend Rate $1.28
  • Forward Annual Dividend Yield 0.59%
  • Payout Ratio 0.54%
  • Dividend Date 2019-11-22
  • ExDividend Date 2019-11-07
View More

Bio-Techne Corporation (TECH) Dividend Calendar:

Bio-Techne Corporation pays an annual dividend of $1.28 per share, with a dividend yield of 0.59%.
TECH's last dividend payment was made to shareholders on November 22, 2019.
Bio-Techne Corporation pays out 54% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Bio-Techne Corporation (TECH) Earnings Estimates:

An earnings estimate is an analyst's estimate for a company's future quarterly or annual earnings per share (EPS). Future earnings estimates are arguably the most important data when attempting to value a firm.

TECH's EPS estimate for the current year is $4.59
Date Period Number of Analysts Average Estimate Low Estimate High Estimate
2020-06-30Year6$4.98$4.84$5.11
2021-06-30Year6$5.74$5.44$6.12
2019-12-31Quarter6$1.15$1.10$1.2
2020-03-31Quarter4$1.31$1.25$1.36

Bio-Techne Corporation (TECH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Reported EPS EPS Estimate Deviation from Estimate
2019-10-282019-10-29$1.06$1.050.95%
2019-06-302019-08-06$1.25$1.33-6.02%
2019-03-312019-05-02$1.21$1.146.14%
2018-12-312019-02-05$1.06$0.988.16%
2018-09-302018-10-30$0.98$0.953.16%
2018-06-302018-08-07$1.34$1.293.88%
2018-03-312018-05-02$1.21$1.146.14%
2017-12-312018-02-06$1.02$0.9210.87%
2017-09-302017-11-01$0.90$0.882.27%
2017-06-302017-08-08$1.09$0.9910.1%
2017-03-312017-05-02$0.97$0.934.3%
2016-12-312017-02-07$0.81$0.85-4.71%
2016-09-302016-08-17$0.43$0.796.3%

Bio-Techne Corporation (TECH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Bio-Techne Corporation (TECH) Chart:

Bio-Techne Corporation (TECH) News:

Below you will find a list of latest news for Bio-Techne Corporation (TECH) from major news sources. You can filter the results to only show news from a specific source.

Date Source Link Headline

Bio-Techne Corporation (TECH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2019-12-201400CALL 99.01FALSE00
2019-12-201450CALL 91.58FALSE00
2019-12-201500CALL 84.4FALSE00
2019-12-201550CALL 77.44FALSE00
2019-12-201600CALL 70.71FALSE00
2019-12-201650CALL 64.18FALSE00
2019-12-201700CALL 57.83FALSE00
2019-12-201750CALL 51.66FALSE00
2019-12-201800CALL 45.64FALSE00
2019-12-201850CALL 39.77FALSE00
2019-12-201900CALL 49.1FALSE00
2019-12-201950CALL 41.95FALSE00
2019-12-2020019CALL1 137FALSE190
2019-12-202106.3CALL1 126.82FALSE2.20.54
2019-12-202203CALL50 5023.28FALSE30
2019-12-202300CALL 0FALSE00
2019-12-202400.4CALL1 30FALSE-1.7-0.81
2019-12-202500CALL 0FALSE00
2019-12-202600CALL 0FALSE00
2019-12-202700CALL 0FALSE00
2019-12-202800CALL 0FALSE00
2019-12-202900CALL 0FALSE00
2019-12-203000CALL 0FALSE00
2019-12-201400PUT 0FALSE00
2019-12-201450PUT 0FALSE00
2019-12-201500PUT 0FALSE00
2019-12-201550PUT 0FALSE00
2019-12-201600PUT 0FALSE00
2019-12-201650PUT 0FALSE00
2019-12-201700PUT 0FALSE00
2019-12-201750PUT 0FALSE00
2019-12-201800PUT 0FALSE00
2019-12-201850PUT 0FALSE00
2019-12-201900PUT 0FALSE00
2019-12-201950PUT 0FALSE00
2019-12-202008.2PUT2 20FALSE8.20
2019-12-202104PUT2 20FALSE40
2019-12-202204PUT4 21.84FALSE40
2019-12-202300PUT 9.05FALSE00
2019-12-202400PUT 0.37FALSE00
2019-12-202500PUT 19.6FALSE00
2019-12-202600PUT 5.03FALSE00
2019-12-202700PUT 0FALSE00
2019-12-202800PUT 40.48FALSE00
2019-12-202900PUT 49.53FALSE00
2019-12-203000PUT 57.38FALSE00
2020-01-171700CALL 40.03FALSE00
2020-01-171750CALL 35.88FALSE00
2020-01-171800CALL 31.83FALSE00
2020-01-171850CALL 34.78FALSE00
2020-01-171900CALL 30.38FALSE00
2020-01-171950CALL 29.64FALSE00
2020-01-1720011.3CALL3 126.22TRUE-8-0.41
2020-01-172109.16CALL1 522.88FALSE2.170.31
2020-01-172204CALL2 721.58FALSE1.950.95
2020-01-172301CALL6 621.06FALSE10
2020-01-172401.3CALL1 20FALSE-0.7-0.35
2020-01-171700PUT 0FALSE00
2020-01-171750PUT 0FALSE00
2020-01-171800PUT 0FALSE00
2020-01-171850PUT 0FALSE00
2020-01-171909PUT3 30FALSE90
2020-01-171950PUT 0FALSE00
2020-01-172000PUT 0FALSE00
2020-01-1721023PUT10 1124.26TRUE230
2020-01-172207.6PUT2 2020.87FALSE-15.8-0.68
2020-01-172300PUT 18.11FALSE00
2020-01-1724028.9PUT20 4516.13TRUE-2.3-0.07
2020-04-171450CALL 26.38FALSE00
2020-04-171500CALL 33.67FALSE00
2020-04-171550CALL 30.62FALSE00
2020-04-171600CALL 32.57FALSE00
2020-04-171650CALL 30.05FALSE00
2020-04-1717032.47CALL1 130.27FALSE32.470
2020-04-171750CALL 27.94FALSE00
2020-04-171800CALL 27.28FALSE00
2020-04-171850CALL 27.9FALSE00
2020-04-171900CALL 26.61FALSE00
2020-04-171950CALL 26.15FALSE00
2020-04-172000CALL 25.31FALSE00
2020-04-172100CALL 24.31FALSE00
2020-04-1722010.9CALL4 723.13FALSE1.90.21
2020-04-172308.8CALL1 2222.07FALSE1.80.26
2020-04-172400CALL 22.59FALSE00
2020-04-172500CALL 20.95FALSE00
2020-04-172600CALL 0FALSE00
2020-04-172700CALL 0FALSE00
2020-04-171450PUT 0FALSE00
2020-04-171500PUT 0FALSE00
2020-04-171550PUT 0FALSE00
2020-04-171600PUT 0FALSE00
2020-04-171656.7PUT10 100FALSE6.70
2020-04-171700PUT 0FALSE00
2020-04-171750PUT 0FALSE00
2020-04-171800PUT 30.97FALSE00
2020-04-171850PUT 29.48FALSE00
2020-04-171902.1PUT5 428.14FALSE-3.9-0.65
2020-04-171950PUT 27.33FALSE00
2020-04-172004.4PUT2 1226.1FALSE-3.5-0.44
2020-04-172100PUT 25.36FALSE00
2020-04-172200PUT 24.15FALSE00
2020-04-172300PUT 23.17FALSE00
2020-04-172400PUT 23.58FALSE00
2020-04-1725056PUT20 2024.27TRUE560
2020-04-172600PUT 24.45FALSE00
2020-04-172700PUT 26.64FALSE00
2020-07-171400CALL 25.91FALSE00
2020-07-171450CALL 29.04FALSE00
2020-07-171500CALL 27.34FALSE00
2020-07-171550CALL 27.96FALSE00
2020-07-171600CALL 28.11FALSE00
2020-07-171650CALL 27.96FALSE00
2020-07-171700CALL 27.41FALSE00
2020-07-171750CALL 26.73FALSE00
2020-07-171800CALL 25.95FALSE00
2020-07-171850CALL 25.79FALSE00
2020-07-171900CALL 25.36FALSE00
2020-07-171950CALL 25.31FALSE00
2020-07-172000CALL 25.06FALSE00
2020-07-172100CALL 23.8FALSE00
2020-07-172200CALL 23.33FALSE00
2020-07-172300CALL 22.86FALSE00
2020-07-172400CALL 22.57FALSE00
2020-07-172505.3CALL13 1322.39FALSE5.30
2020-07-172600CALL 22.51FALSE00
2020-07-172700CALL 18.68FALSE00
2020-07-172800CALL 0FALSE00
2020-07-172900CALL 0FALSE00
2020-07-173000CALL 0FALSE00
2020-07-171400PUT 0FALSE00
2020-07-171450PUT 0FALSE00
2020-07-171500PUT 0FALSE00
2020-07-171550PUT 0FALSE00
2020-07-171600PUT 0FALSE00
2020-07-171650PUT 31.42FALSE00
2020-07-171700PUT 31.04FALSE00
2020-07-171750PUT 28.94FALSE00
2020-07-171800PUT 28.92FALSE00
2020-07-171850PUT 27.89FALSE00
2020-07-171900PUT 27.51FALSE00
2020-07-171950PUT 27.19FALSE00
2020-07-172000PUT 26.39FALSE00
2020-07-172100PUT 25.68FALSE00
2020-07-172200PUT 24.56FALSE00
2020-07-172300PUT 24.42FALSE00
2020-07-172400PUT 24.05FALSE00
2020-07-172500PUT 24.67FALSE00
2020-07-172600PUT 25.36FALSE00
2020-07-172700PUT 26.11FALSE00
2020-07-172800PUT 27.07FALSE00
2020-07-172900PUT 30.03FALSE00
2020-07-173000PUT 32.85FALSE00

Latest TECH Trades:

Date Shares Price
Dec 9, 2019 8:58 PM EST49$219.09
Dec 9, 2019 8:58 PM EST21$219.09
Dec 9, 2019 8:58 PM EST200$219.105
Dec 9, 2019 8:58 PM EST50$219.26
Dec 9, 2019 8:59 PM EST100$219.34

Bio-Techne Corporation (TECH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000021545718005898/0000215457-18-005898-index.htm
2019-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000021545719000933/0000215457-19-000933-index.htm
2018-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000257/0000914190-19-000257-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000258/0000914190-19-000258-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000259/0000914190-19-000259-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000260/0000914190-19-000260-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000093247119004923/0000932471-19-004923-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000139834419002785/0001398344-19-002785-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774918009213/0001437749-18-009213-index.htm
2018-05-25SDhttps://www.sec.gov/Archives/edgar/data/842023/000143774918010740/0001437749-18-010740-index.htm
2018-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918012358/0001437749-18-012358-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918014310/0001437749-18-014310-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918014634/0001437749-18-014634-index.htm
2018-08-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774918016190/0001437749-18-016190-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918016625/0001437749-18-016625-index.htm
2018-09-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/842023/000143774918016854/0001437749-18-016854-index.htm
2018-09-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/842023/000143774918016855/0001437749-18-016855-index.htm
2018-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918018887/0001437749-18-018887-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918018994/0001437749-18-018994-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774918019736/0001437749-18-019736-index.htm
2018-11-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/842023/000143774918019746/0001437749-18-019746-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919001827/0001437749-19-001827-index.htm
2019-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919002066/0001437749-19-002066-index.htm
2019-04-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000143774919007189/0001437749-19-007189-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919008208/0001437749-19-008208-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919008875/0001437749-19-008875-index.htm
2019-05-29SDhttps://www.sec.gov/Archives/edgar/data/842023/000143774919010933/0001437749-19-010933-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919012693/0001437749-19-012693-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919015521/0001437749-19-015521-index.htm
2019-08-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919017565/0001437749-19-017565-index.htm
2019-09-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/842023/000143774919018072/0001437749-19-018072-index.htm
2019-09-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/842023/000143774919018073/0001437749-19-018073-index.htm
2019-10-0910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919019836/0001437749-19-019836-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919020780/0001437749-19-020780-index.htm
2019-11-0610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919021760/0001437749-19-021760-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919021764/0001437749-19-021764-index.htm
2018-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002166/0001562180-18-002166-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003561/0001562180-18-003561-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003802/0001562180-18-003802-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm
2019-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003803/0001562180-19-003803-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm

Bio-Techne Corporation (TECH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bio-Techne Corporation (TECH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 95%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-12Norman David EansorSVP - Novus BiologicalsSell3,117.00215.00670,155.000.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm
2019-09-09Charles R. KummethChief Executive OfficerBuy100.00185.0018,500.00100.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell6,566.00212.751,396,910.59102,579.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-08-07Charles R. KummethChief Executive OfficerBuy11,291.000.000.00103,467.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm
2019-07-09Charles R. KummethChief Executive OfficerBuy15,037.0067.461,014,396.02107,213.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-11-22James HippelChief Financial OfficerSell22,051.00215.554,753,051.1510,907.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-07-10Charles R. KummethChief Executive OfficerBuy16,969.0067.461,144,728.74109,145.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-07-08Charles R. KummethChief Executive OfficerBuy17,994.0067.461,213,875.24110,170.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-08-13Charles R. KummethChief Executive OfficerBuy7,410.0067.46499,878.60110,877.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm
2019-11-25Roeland NusseDirectorSell8,347.00219.331,830,730.8212,374.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2018-10-25Alpna SethDirectorBuy514.000.000.001,253.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm
2018-10-25JOSEPH D KEEGANDirectorBuy514.000.000.001,253.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm
2018-08-24ROBERT V BAUMGARTNERDirectorBuy5,000.0061.46307,300.0012,712.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2018-08-23JOHN L HIGGINSDirectorBuy10,000.0061.08610,800.0013,012.00https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2018-08-08Charles A DinarelloDirectorBuy5,000.0063.03315,150.0013,212.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2019-11-29Charles R. KummethChief Executive OfficerSell100.00222.6222,262.36135,756.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-08-19Charles R. KummethChief Executive OfficerBuy24,979.000.00135,856.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm
2019-11-27Charles R. KummethChief Executive OfficerSell11,772.00222.122,614,814.30135,856.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-07-01RUPERT VESSEYDirectorBuy147.000.000.00147.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm
2019-11-27Charles R. KummethChief Executive OfficerBuy11,772.0067.46794,139.12147,628.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-11-25Roeland NusseDirectorBuy10,000.0060.46604,600.0015,721.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2019-05-01Kim KeldermanPresident, Diagnostics & GenomBuy1,667.00202.13336,950.711,667.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm
2019-10-24Alpna SethDirectorBuy495.000.000.001,748.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm
2019-10-24JOSEPH D KEEGANDirectorBuy495.000.000.001,748.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm
2019-11-21James HippelChief Financial OfficerBuy11,349.0094.351,070,778.1520,656.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-25Roeland NusseDirectorBuy5,000.0061.46307,300.0020,721.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2019-05-24Brenda S. FurlowSVP - General CounselSell5,400.00200.001,080,000.002,189.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2018-05-04Norman David EansorSVP - Novus BiologicalsSell1,136.00145.19164,931.752,266.00https://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm
2019-08-19Norman David EansorSVP - Novus BiologicalsBuy2,287.000.002,287.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm
2018-08-07Brenda S. FurlowSVP - General CounselBuy959.000.000.002,627.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm
2018-08-23JOHN L HIGGINSDirectorSell10,000.00187.921,879,173.003,012.00https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2019-11-22James HippelChief Financial OfficerBuy23,651.0094.352,231,471.8532,958.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2018-08-07Norman David EansorSVP - Novus BiologicalsBuy1,199.000.000.003,465.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm
2018-10-25JOHN L HIGGINSDirectorBuy514.000.000.003,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm
2019-06-04JOHN L HIGGINSDirectorSell5,000.00203.671,018,345.503,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2019-05-01James HippelChief Financial OfficerBuy35,000.0086.253,018,750.0039,382.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2019-08-19Brenda S. FurlowSVP - General CounselBuy1,759.000.003,948.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm
2019-10-24JOHN L HIGGINSDirectorBuy495.000.000.004,021.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm
2018-10-25RANDOLPH C STEERDirectorBuy514.000.000.004,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm
2019-05-01James HippelChief Financial OfficerSell35,000.00203.087,107,681.004,382.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2019-10-24RANDOLPH C STEERDirectorBuy495.000.000.004,721.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm
2018-10-25HAROLD J WIENSDirectorBuy514.000.000.004,726.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm
2019-10-24HAROLD J WIENSDirectorBuy495.000.000.005,221.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm
2019-12-04HAROLD J WIENSDirectorSell80.00219.3117,545.115,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2018-10-25Roeland NusseDirectorBuy514.000.000.005,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm
2019-12-04HAROLD J WIENSDirectorSell921.00218.75201,472.895,301.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2018-08-07James HippelChief Financial OfficerBuy2,398.000.000.005,477.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm
2019-10-24Roeland NusseDirectorBuy495.000.000.005,721.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm
2019-12-04HAROLD J WIENSDirectorSell514.00217.29111,684.596,222.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-10-24RUPERT VESSEYDirectorBuy495.000.000.00642.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm
2019-12-04HAROLD J WIENSDirectorSell485.00216.47104,990.236,736.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-12-04HAROLD J WIENSDirectorBuy2,000.0087.83175,660.007,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-05-24Brenda S. FurlowSVP - General CounselBuy5,400.000.000.007,589.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2018-06-07Charles R. KummethChief Executive OfficerSell8,000.00160.001,280,000.0076,472.00https://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm
2018-08-24ROBERT V BAUMGARTNERDirectorSell5,000.00188.47942,333.507,712.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2018-08-08Charles A DinarelloDirectorSell5,000.00176.94884,675.008,212.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2018-10-25ROBERT V BAUMGARTNERDirectorBuy514.000.000.008,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm
2019-06-04JOHN L HIGGINSDirectorBuy5,000.0063.03315,150.008,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2019-08-07ROBERT V BAUMGARTNERDirectorBuy500.00191.0695,530.008,726.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm
2018-08-07Charles R. KummethChief Executive OfficerBuy13,816.000.000.0090,288.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm
2019-07-08Charles R. KummethChief Executive OfficerSell17,994.00212.753,828,183.9192,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-09Charles R. KummethChief Executive OfficerSell15,037.00212.433,194,339.9892,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell494.00214.07105,749.6992,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-10-24ROBERT V BAUMGARTNERDirectorBuy495.000.000.009,221.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell9,909.00213.322,113,768.0692,670.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-08-19James HippelChief Financial OfficerBuy4,925.000.009,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm
2019-11-21James HippelChief Financial OfficerSell11,349.00215.362,444,131.999,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-22James HippelChief Financial OfficerSell1,600.00216.16345,850.249,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2018-08-08Charles R. KummethChief Executive OfficerBuy11,279.000.000.0093,514.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm